Patents by Inventor Arlene Stecenko

Arlene Stecenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cystic fibrosis transmembrane-conductance regulator (cftr)-membrane translocation sequence fusion protein (cftr-mts) as a therapeutic agent
    Publication number: 20040047808
    Abstract: The present invention provides a method of treating cystic fibrosis in a human subject diagnosed with cystic fibrosis, comprising administering to the subject, in a pharmaceutically acceptable carrier, an effective amount of a fusion protein, comprising a cystic fibrosis transmembrane conductance regulator (CFTR) and a membrane translocation sequence (MST), whereby the fusion protein can be taken up by affected cells in the subject, thereby treating cystic fibrosis. The present invention also provides a fusion protein comprising a cystic fibrosis transmembrane conductance regulator and a membrane translocation sequence.
    Type: Application
    Filed: October 20, 2003
    Publication date: March 11, 2004
    Inventors: Arlene Stecenko, Kenneth Birgham, Mauricio Rojas
  • Gene delivery and expression in areas inaccessible to direct protein delivery
    Publication number: 20020142984
    Abstract: The present invention provides novel methods for gene delivery and expression in areas that are currently inaccessible through the use of conventional direct protein delivery techniques. In particular, the methods and related products provided herein can be used in the treatment of &agr;1 antitrypsin (AAT) related disorders such as respiratory syncytial virus (RSV) infection.
    Type: Application
    Filed: December 20, 2001
    Publication date: October 3, 2002
    Applicant: Vanderbilt University
    Inventors: Kenneth Brigham, Angelo Canonico, Barbara Meyrick, Arlene Stecenko
  • Gene delivery and expression in areas inaccessible to direct protein delivery
    Patent number: 6365575
    Abstract: The present invention provides novel methods for gene delivery and expression in areas that are currently inaccessible through the use of conventional direct protein delivery techniques. In particular, the methods and related products provided herein can be used in the treatment of &agr;1 antitrypsin (AAT) related disorders such as respiratory syncytial virus (RSV) infection.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: April 2, 2002
    Assignee: Vanderbilt University
    Inventors: Kenneth Brigham, Angelo Canonico, Barbara Meyrick, Arlene Stecenko